Helicobacter pylori Eradication Rates and Related Factors by Second-Line Bismuth-Based Quadruple Therapy

被引：1
|
作者：
Kim, Sung Eun
Park, Moo In
Park, Seun Ja
Moon, Won
Lee, Jun Yeob
Lee, Jin Wook
Kim, Hae Koo
Nam, Kyoung Sik
Nam, Yong Jin
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)32975-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1350
引用
收藏
页码：S881 / S881
页数：1
相关论文
共 50 条
  • [41] Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    Bai, Peng
    Xue, Yan
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (05) : 506 - 511
  • [42] Levofloxacin, Bismuth, Amoxicillin and Esomeprazole As Second-Line Helicobacter pylori Therapy After Failure of Non-Bismuth Quadruple Therapy
    Song, Zhiqiang
    Zhou, Liya
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S879 - S879
  • [43] THE APPROPRIATE CUT-OFF GASTRIC PH VALUE FOR HELICOBACTER PYLORI ERADICATION WITH BISMUTH-BASED QUADRUPLE THERAPY
    Li, Jing
    Wang, Jiamin
    Lu, Bingyun
    Chen, Ye
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S856 - S856
  • [44] Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
    Seyyedmajidi, Mohamadreza
    Abbasi, Laleh
    Seyedmajidi, Seyedali
    Hosseini, Seyed Ashkan
    Ahmadi, Anahita
    Hajiebrahimi, Shahin
    Vafaeimanesh, Jamshid
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2019, 10 (02) : 211 - 216
  • [45] Efficacy of 7-day bismuth-based quadruple therapy versus 14-day moxifloxacinbased triple therapy for second-line treatment of Helicobacter Pylori infection
    Kim, S.
    Roh, J.
    Park, M.
    Park, S.
    Moon, W.
    Kim, J.
    Jung, K.
    Seol, S.
    [J]. HELICOBACTER, 2016, 21 : 142 - 142
  • [46] The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy
    Megraud, Francis
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (02) : 103 - 109
  • [47] Eradication rate of Bismuth-containing quadruple therapy as a second-line treatment for H-pylori infection
    Jee, S. R.
    Lee, S. H.
    Jung, E. U.
    Ok, K. S.
    Kim, J. H.
    Choi, J. S.
    Lee, Y. J.
    Seol, S. Y.
    [J]. HELICOBACTER, 2010, 15 (04) : 345 - 345
  • [48] Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial
    Liou, Jyh-Ming
    Jiang, Xiao-Tao
    Chen, Chieh-Chang
    Luo, Jiing-Chyuan
    Bair, Ming-Jong
    Chen, Po-Yueh
    Chou, Chu-Kuang
    Fang, Yu-Jen
    Chen, Mei-Jyh
    Chen, Chien-Chuan
    Lee, Ji-Yuh
    Yang, Tsung-Hua
    Yu, Chien-Chun
    Kuo, Chia-Chi
    Chiu, Min-Chin
    Chen, Chi-Yi
    Shun, Chia-Tung
    Hu, Wen-Hao
    Tsai, Min-Horn
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Chang, Chi-Yang
    Lin, Jaw-Town
    El-Omar, Emad M.
    Wu, Ming-Shiang
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (03): : 228 - 241
  • [49] Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
    Chung, Jun-Won
    Lee, Jeong Hoon
    Jung, Hwoon-Yong
    Yun, Sung-Cheol
    Oh, Tae-Hoon
    Choi, Kee Don
    Song, Ho June
    Lee, Gin Hyug
    Kim, Jin-Ho
    [J]. HELICOBACTER, 2011, 16 (04) : 289 - 294
  • [50] Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication
    Korman, MG
    Bolin, TD
    Engelman, JL
    Pianko, S
    [J]. HELICOBACTER, 1997, 2 (03) : 140 - 143
12345